Related Experiment Videos
Clinical Prediction Models in Cardiovascular Disease: Foundations, Clinical Applications and Future Directions
Bingyi Wang1, Alessandro N Franciosi1, Linda O'Neill1
1Clinical Research Centre, School of Medicine University College Dublin Dublin Ireland.
Abstract:
Clinical prediction models have progressed from traditional risk scores derived from epidemiological cohorts into sophisticated systems capable of integrating multimodal data, electronic health records, and machine learning approaches. This review provides a clinically focused synthesis of the clinical prediction model lifecycle, outlining their conceptual foundations and methodological evolution across health care settings, with particular emphasis on cardiovascular risk prediction. These predictive frameworks inform both population-level public health strategies and individual clinical decision-making. However, external validation studies frequently reveal a stark discrepancy between statistical performance and real-world implementation, driven by temporal calibration drift, geographic transportability failures, and systemic sociodemographic or sex-based biases. Importantly, clinical prediction models should not be viewed as replacements for randomized trial evidence; instead, they function as vital complementary mechanisms to dissect the heterogeneity of treatment effects and individualize treatment decisions by contextualizing average treatment effects at the bedside. As health care shifts toward data-driven infrastructures, this review aims to contextualize the bench-to-bedside translational gap, offering an evidence-based roadmap for clinicians, statisticians, and data scientists to safely harness predictive modeling and ensure meaningful improvements in patient outcomes.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction
Model Approaches for Pharmacokinetic Data: Physiological Models
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Pharmacodynamic Models: Overview